CTOs on the Move

Surgalign

www.surgalign.com

 
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies physicians and other health providers will look to for what is truly possible for their patients. Surgalign is focused on developing solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in approximately 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design ...
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.surgalign.com
  • 520 Lake Cook Road Suite 315
    Deerfield, IL USA 60015
  • Phone: 844.894.7752

Executives

Name Title Contact Details
Alexander Neff
Sr. Director Information Security Profile

Similar Companies

Qi Imaging

Qi Imaging is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Medical Electronics Corporation

Advanced Medical Electronics Corporation is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Imaging

Advanced Imaging is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

InfiMed

InfiMed, Inc. is a Liverpool, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CeQur

CeQur is dedicated to helping people with type 2 diabetes manage their disease by developing and commercializing simple drug delivery devices that can be easily integrated into daily life. The company`s lead product, PaQ, is a wearable insulin delivery device that delivers both basal and bolus insulin for 3 days at a time. Its simple, discreet design enables people to easily experience the benefits of intensive insulin therapy, while remaining free from the burdens of daily insulin injections. CeQur SA was established in January 2008 as a spinout from Danfoss A/S, a global Danish industrial products group that developed the initial concept of the CeQur technology. CeQur recently completed a clinical study evaluating PaQ among people with type 2 diabetes with positive results. The company has advanced the technology to a commercial product obtaining a CE mark for PaQ in 2012. CeQur is headquartered in Horw, Switzerland, with operations in Nordborg, Denmark and Marlborough, Massachusetts.